References
- Halken S, Muraro A, de Silva D, et al. EAACI guideline: Preventing the
development of food allergy in infants and young children (2020
update). Pediatr Allergy Immunol. 2021 Mar 12:1-16.
- Knol EF, de Jong NW, Ulfman LH, et al. Management of Cow’s Milk
Allergy from an Immunological Perspective: What Are the
Options.Nutrients.2019,11(11):2734.
- Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis,
diagnosis, and treatment. J Allergy Clin Immunol 2014, 133: 291–307.
- Savage J, Johns CB. Food allergy: epidemiology and natural history.
Immunol Allergy Clin North Am 2015, 35: 45–59.
- Bingol A, Uygun DFK, Akdemir M, et al. Clinical phenotypes of
childhood food allergies based on immune mechanisms: A multicenter
study. Allergy Asthma Proc. 2021 May 1, 42(3): e86-e95
- Boné Calvo J, Clavero Adell M, Guallar Abadía I, et al. As soon as
possible in IgE-cow’s milk allergy immunotherapy. Eur J Pediatr. 2021
Jan; 180(1):291-294. .
- Martorell Calatayud C, Muriel García A, Martorell Aragonés A, et al.
Safety and efficacy profile and immunological changes associated with
oral immunotherapy for IgE mediated cow’s milk allergy in children:
systematic review and meta-analysis. J Investig Allergol Clin
Immunol.2014, 24(5):298–307.
- Sabouraud M, Biermé P, Andre-Gomez SA, et al. Oral immunotherapy in
food allergies: A practical update for pediatricians. Arch Pediatr.
2021 May; 28(4):319-324.
- Demir E, Ciğerci Günaydın N, Gülen F, et al. Oral Immunotherapy for
Cow’s Milk Allergy: Five Years’ Experience from a Single Center in
Turkey. Balkan Med J. 2020 Oct 23; 37(6):316-323.
- Julian Higgins, James Thoma, Jacqueline Chandler, et al. Cochrane
Handbook for Systematic Reviews of Interventions. Version 6.2,
Available from http://www.cochrane-handbook.org/: The Cochrane
Collaboration, 2021.
- Morisset M, Moneret-Vautrin DA, Guenard L, et al. Oral desensitization
in children with milk and egg allergies obtains recovery in a
significant proportion of cases. A randomized study in 60 children
with cow’s milk allergy and 90 children with egg allergy. Eur Ann
Allergy Clin Immunol. 2007, 39(1): 12-19.
- Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in
children with very severe cow’s milk-induced reactions. J Allergy Clin
Immunol.2008, 121(2): 343-347.
- Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind,
placebo-controlled study of milk oral immunotherapy for cow’s milk
allergy. J Allergy Clin Immunol. 2008,122(6): 1154-1160.
- Pajno G, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow’s
milk allergy with a weekly up-dosing regimen: a randomized
single-blind controlled study. Ann Allergy Asthma Immunol. 2010 Nov;
105(5):376-381.
- Martorell A, De la Hoz B, Ibanez MD, et al. Oral desensitization as a
useful treatment in 2-year-old children with cow’s milk allergy Clin
Exp Allergy.2011,41(9): 1297-1304.
- Salmivesi S, Korppi M, Makela M J, et al. Milk oral immunotherapy is
effective in school-aged children. Acta Paediatr. 2012, 102(2):
172-176.
- Lee J. H., Kim W.S, Kim H, et al. Increased cow’s milk
protein-specific IgG4 levels after oral desensitization in 7- to
12-month-old infants. Ann Allergy Asthma Immunol. 2013,111(6):
523-528.
- Takahashi M, Soejima K, Taniuchi S, et al. Oral immunotherapy combined
with omalizumab for high-risk cow’s milk allergy: a randomized
controlled trial. Sci Rep.2017, 7(1): 17453.
- Esmaeilzadeh H, Alyasin S, Haghighat M, et al. The effect of baked
milk on accelerating unheated cow’s milk tolerance: A control
randomized clinical trial. Pediatr Allergy Immunol. 2018, 29(7):
747-753.
- De Schryver S, Mazer B, Clarke A E, et al. Adverse Events in Oral
Immunotherapy for the Desensitization of Cow’s Milk Allergy in
Children: A Randomized Controlled Trial. J Allergy Clin Immunol. 2019,
Pract 7(6): 1912-1919.
- Maeda M, Imai T, Ishikawa R, et al. Effect of oral immunotherapy in
children with milk allergy: The ORIMA study. Allergol Int, 2021,
70(2): 223-228.
- Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for
IgE-mediated cow’s milk allergy: a systematic review and
meta-analysis. Clin Exp Allergy. 2012, 42:363-374.
- Yeung JP, Kloda LA, McDevitt J, et al. Oral immunotherapy for milk
allergy. Cochrane Database Syst Rev. 2012,11: CD009542.
doi:10.1002/14651858. CD009542. pub2.
- Martorell CC, Muriel GA, Martorell AA, et al. Safety and efficacy
profile and immunological changes associated
with oral immunotherapy for IgE-mediated cow’s milk allergy in children:
systematic review and meta-analysis. J Investig Allergol Clin Immunol.
2014; 24(5):298-307.
- Fisher HR, Du Toit G, Lack G. Specific oral tolerance induction in
food allergic children: is oral desensitization more effective than
allergen avoidance? Arch Dis Child. 2011,96:259-264
- Nurmatov U, Dhami S, Arasi S, et al. Allergen immunotherapy for
IgE-mediated food allergy: a systematic review and
meta-analysis.Allergy.2017,72:1133–1147.
- Staden U, Rolinck-Werninghaus C, Brewe F, et al. Specific oral
tolerance induction in food allergy in children: efficacy and clinical
patterns of reaction. Allergy. 2007, 62: 1261–1269.
- Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety
and efficacy of sublingual and oral immunotherapy for milk allergy. J
Allergy Clin Immunol 2012, 129:448-455.
- Wood RA, Kim JS, Lindblad R, et al. A randomized, double-blind,
placebo-controlled study of omalizumab combined with oral
immunotherapy for the treatment of cow’s milk allergy. J Allergy Clin
Immunol. 2016 Apr, 137(4):1103-1110.e11.
- Flore A, Charlotte K, Wanda G, et al. Is a slow-progression baked-milk
protocol of oral immunotherapy always a safe option for children with
cow’s milk allergy? A randomized controlled trial. Clin Exp
Allergy.2017 Nov, 47(11):1491-1496.
- Chisato Inuo, Kenichi Tanaka, Satoko Suzuki, et al. Oral Immunotherapy
Using Partially
Hydrolyzed Formula for Cow’s Milk Protein Allergy: A Randomized,
Controlled Trial. Int Arch Allergy Immunol. 2018, 177(3):259-268.
- Nagakura K, Sato S, Miura Y, et al. A randomized trial of oral
immunotherapy for pediatric cow’s milk-induced anaphylaxis: Heated vs
unheated milk. Pediatr Allergy Immunol. 2021, 32: 161–169.
- Carraro S, Frigo A.C, Perin M, et al. Impact of oral immunotherapy on
quality of life in children with cow milk allergy: a pilot study. Int
J Immunopathol Pharmacol.2012, 25(3):793-798.
- Epstein-Rigbi N, Goldberg MR, Levy MB, et al. Changes in patient
quality of life during oral immunotherapy for food allergy. Allergy.
2017, 72:1883–1890.
- Epstein-Rigbi N, Goldberg MR, Levy MB, et al. Quality of life of
children aged 8-12 years undergoing food allergy oral immunotherapy:
Child and parent perspective. Allergy. 2020, 75: 2623–2632.
- Perezabad L, Reche M, Valbuena T, et al. Oral food desensitization in
children with IgE mediated cow’s milk allergy: immunological changes
underlying desensitization. Allergy Asthma Immunol Res. 2017,
9(1):35-42.
- Ebrahimi M, Gharagozlou M, Mohebbi A, et al. The Efficacy of Oral
Immunotherapy in Patients with Cow’s Milk Allergy. Iran J Allergy
Asthma Immunol. 2017June, 16(3):183-192.
- Gruzelle V, Juchet A, Martin-Blondel A, et al. Benefits of baked milk
oral immunotherapy in French children with cow’s milk allergy. Pediatr
Allergy Immunol. 2020, 31:364–370.
- Goldberg MR, Nachshon L, Appel MY, et al. Efficacy of baked milk oral
immunotherapy in baked milk–reactive allergic patients. J Allergy
Clin Immunol. 2015,136:1601-1606.
- Nadeau KC, Schneider LC, Hoyte L, et al. Rapid oral desensitization in
combination with omalizumab therapy in patients with cow’s milk
allergy. J Allergy Clin Immunol. 2011,127: 1622–1624.
- Martorell-Calatayud C, Michavila-Go´ mez A, Martorell-Aragone´s A, et
al. Anti IgE-assisted desensitization to egg and cow’s milk in
patients’ refractory to conventional oral immunotherapy. Pediatr
Allergy Immunol. 2016, 27:544–546.Figure LegendsFigure 1. Results from searching for studies for inclusion in the
review.
Figure 2. (A) The summary of risk of bias; (B) Each risk of bias item
for each included study;
(C) Funnel plot of studies.
Figure 3. Efficacy of OIT (A: Desensitization; B: subgroup analysis of
desensitization in patients older than 3-years-old; C: partial
desensitization).
Figure 4. Adverse events of OIT(A: serious adverse events; B:
non-serious adverse events; C: epinephrine use; D: treatment
discontinuation) .
Author Contributions
Lujing Tang: Conceptualization(lead); Data curation(lead); Formal
analysis(lead); Methodology(lead);Writing-original
draft(lead);Writing-review and editing(lead). Yu Yu: Data
curation(equal). Xiangyuan Pu: Writing-review and
editing(equal). Jie Chen: Conceptualization(lead);
Writing-review and editing(equal); Supervision (lead).